The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized, double blind, placebo-controlled crossover trial of a sustained release methylphenidate in cancer-related fatigue.
Carmelita P. Escalante
No relevant relationships to disclose
Christina A. Meyers
No relevant relationships to disclose
James M. Reuben
No relevant relationships to disclose
Xuemei Wang
No relevant relationships to disclose
Wei Qiao
No relevant relationships to disclose
Ellen F. Manzullo
No relevant relationships to disclose
Ricardo H. Alvarez
No relevant relationships to disclose
Phuong Khanh H. Morrow
No relevant relationships to disclose
Ana M. Gonzalez-Angulo
No relevant relationships to disclose
Tito R. Mendoza
No relevant relationships to disclose
Xin Shelley Wang
No relevant relationships to disclose
Wenli Liu
No relevant relationships to disclose
Holly Michelle Holmes
No relevant relationships to disclose
Jessica Hwang
No relevant relationships to disclose
Katherine Pisters
No relevant relationships to disclose
Michael J. Overman
No relevant relationships to disclose
Charles S. Cleeland
No relevant relationships to disclose